Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INCYTE CORP Director's Dealing 2026

Feb 23, 2026

30371_dirs_2026-02-23_83c51ec4-a5fb-407a-9f54-5fdf5f910ea3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2026-02-19

Reporting Person: CAGNONI PABLO J (President, R&D)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-19 Common Stock M 13093 $61.76 Acquired 247893 Direct
2026-02-19 Common Stock M 5575 $61.18 Acquired 253468 Direct
2026-02-19 Common Stock S 18668 $100.91 Disposed 234800 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-19 Employee Stock Option (right to buy) $61.76 M 13093 Disposed 2033-07-13 Common Stock (13093) Direct
2026-02-19 Employee Stock Option (right to buy) $61.18 M 5575 Disposed 2034-01-17 Common Stock (5575) Direct

Footnotes

F1: This includes an aggregate of 229,661 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.

F2: The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

F3: Beginning January 18, 2024, options become exercisable in 37 installments, with the first 25% vesting on July 14, 2024 and the remainder vesting monthly over three years.